STAT5 is critical to maintain effector CD8+ T cell responses.
about
Regulating the immune system via IL-15 transpresentationThe effects of TLR activation on T-cell development and differentiationMurine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells.Regulation of tissue-dependent differences in CD8+ T cell apoptosis during viral infection.Effects of 1,25-(OH)(2)D (3) on the expressions of vitamin D receptor, STAT5 and cytoskeletal rearrangement in human monocytes incubated with sera from type 2 diabetes patients and diabetic nephropathy patients with uremia.Cytokines and the inception of CD8 T cell responses.Intersection of mTOR and STAT signaling in immunityRegulatory T cells resist virus infection-induced apoptosisEfficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.STAT5 is a potent negative regulator of TFH cell differentiation.Signal integration by Akt regulates CD8 T cell effector and memory differentiation.Generalized Liver- and Blood-Derived CD8+ T-Cell Impairment in Response to Cytokines in Chronic Hepatitis C Virus InfectionStable inhibitory activity of regulatory T cells requires the transcription factor HeliosDifferential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4(+) cell properties during viral infection.NK Cell Proliferation Induced by IL-15 Transpresentation Is Negatively Regulated by Inhibitory Receptors.JAK and STAT signaling molecules in immunoregulation and immune-mediated disease.Disparate roles for STAT5 in primary and secondary CTL responses.IL-15 signaling promotes adoptive effector T-cell survival and memory formation in irradiation-induced lymphopeniaIL-7 signaling and CD127 receptor regulation in the control of T cell homeostasisProtecting and rescuing the effectors: roles of differentiation and survival in the control of memory T cell development.Role of PI3K/Akt signaling in memory CD8 T cell differentiation.Cooperative therapeutic anti-tumor effect of IL-15 agonist ALT-803 and co-targeting soluble NKG2D ligand sMICSTAT3 promotes CD1d-mediated lipid antigen presentation by regulating a critical gene in glycosphingolipid biosynthesis.IL-21 and T Cell Differentiation: Consider the Context.Dying to protect: cell death and the control of T-cell homeostasis.TCF1+ hepatitis C virus-specific CD8+ T cells are maintained after cessation of chronic antigen stimulation.IL-4 and IL-15 promotion of virtual memory CD8+ T cells is determined by genetic background.When Aging Reaches CD4+ T-Cells: Phenotypic and Functional Changes.Peripheral human CD4+CD8+ T lymphocytes exhibit a memory phenotype and enhanced responses to IL-2, IL-7 and IL-15.Temporal Expression of Bim Limits the Development of Agonist-Selected Thymocytes and Skews Their TCRβ Repertoire.Mcl-1 antagonizes Bax/Bak to promote effector CD4(+) and CD8(+) T-cell responses.Longitudinal analysis of whole blood transcriptomes to explore molecular signatures associated with acute renal allograft rejection.Bim controls IL-15 availability and limits engagement of multiple BH3-only proteins.An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cellsThe MicroRNA miR-191 Supports T Cell Survival Following Common γ Chain SignalingBcl-2 allows effector and memory CD8+ T cells to tolerate higher expression of Bim.IL-15 preferentially enhances functional properties and antigen-specific responses of CD4+CD28(null) compared to CD4+CD28+ T cells.STAT5BN642H is a driver mutation for T cell neoplasia.Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype.Stat5 gene dosage in T cells modulates CD8+T-cell homeostasis and attenuates contact hypersensitivity response in mice
P2860
Q26825247-2F84C423-BCA8-4084-A8D9-EC99BE399122Q27001581-C77BA9BF-84FA-4C30-8A53-6E827D3A04AAQ33903561-9D1DC2BF-440D-4C18-BCEC-2522B8F6E8DBQ34059370-930C939D-B93D-433D-B75D-A71445E7BBD1Q34155747-67CF2538-BDC1-448F-AE2A-F09F6AAFFAC9Q34783475-D29BEE6D-4A60-4DB4-A692-49C629CF498BQ34978661-58EE449E-1564-4DE3-89DD-B7E49501F249Q35115564-0ADC5173-0C16-48DE-8C3B-6171B619BD7AQ35171267-910F043D-92B1-4E4D-9CB7-69800B356DEBQ35761809-D0A106F5-1F3A-4125-972D-E07175602E3DQ35903157-27D0B494-EAB9-4296-96B3-89AA357EAC99Q36055483-30382C07-822E-4040-A1BC-7A58CC95B92CQ36233090-E2F1E0D7-501D-450F-A19F-C59313EB8604Q36239323-D630FCCE-8182-4679-9F6B-3A0E48B6ABABQ36260218-672552FB-9C3D-448B-8302-B458F6182994Q36404704-AA5C152A-52AE-401C-AFA0-6CC6DD43F66BQ36718025-72B18374-6DF7-480E-A10C-305B1C1F6872Q36875832-03A8367A-472A-457D-99C5-807A241880E2Q38007051-955A1484-ED48-48D9-B78F-15DC0F9DB632Q38076413-B281ADBB-251F-433D-836A-7B0F630F77F6Q38078934-D3E91276-8730-47EE-AC0C-A883690BDE4DQ38815326-8977EF5E-DCFD-42D1-8DD9-3F08070ADEFCQ38844774-9227DF20-BD6E-44AF-A37A-A9A2FDFCF832Q38889721-F33E562A-667E-4FF6-BB95-B1F99BA83883Q39277476-4BD47531-4EE1-40E9-A745-B8F69572FF66Q40217589-844DC941-BD12-40D5-919B-B09756701681Q40600158-1C9A8D28-373A-46F2-AE46-D36A5A892893Q40602726-C7289FA1-6E55-4FE4-9CA6-235011925B63Q41051473-FA6A43EE-12B3-4E40-86E4-0BA827C9882EQ41502539-354C6749-F4E4-4608-95BE-15A00AC3659BQ41772001-F2982A5D-E1FF-48D8-AFEC-213319CECFACQ41947325-2A69B727-F387-4871-85F8-A583BE9B4FE0Q41966864-11D1B523-AC77-4F96-9CBD-C1B7EAC54989Q42139586-2CECE715-E91F-4009-93E6-AD428993F10AQ42733320-AB91E1C3-E300-4951-944D-68F1D386CE53Q42980651-D090E399-C0B3-40A1-BD19-3352602DB30AQ44704847-6F9154F3-A7C0-4D62-A583-0AFE82D023B2Q47375997-82ECE93D-2411-4BBA-AF07-6F64042264CCQ51760444-51DD3EDB-E90D-407B-8781-A366418F58C2Q58455445-4767CF97-1782-4BC9-B49F-854EAF805480
P2860
STAT5 is critical to maintain effector CD8+ T cell responses.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
STAT5 is critical to maintain effector CD8+ T cell responses.
@ast
STAT5 is critical to maintain effector CD8+ T cell responses.
@en
STAT5 is critical to maintain effector CD8+ T cell responses.
@nl
type
label
STAT5 is critical to maintain effector CD8+ T cell responses.
@ast
STAT5 is critical to maintain effector CD8+ T cell responses.
@en
STAT5 is critical to maintain effector CD8+ T cell responses.
@nl
prefLabel
STAT5 is critical to maintain effector CD8+ T cell responses.
@ast
STAT5 is critical to maintain effector CD8+ T cell responses.
@en
STAT5 is critical to maintain effector CD8+ T cell responses.
@nl
P2093
P2860
P50
P356
P1476
STAT5 is critical to maintain effector CD8+ T cell responses
@en
P2093
Allyson Sholl
Fred D Finkelman
Pulak Tripathi
Sara Wojciechowski
Sema Kurtulus
Suzanne C Morris
P2860
P304
P356
10.4049/JIMMUNOL.1000842
P407
P577
2010-07-19T00:00:00Z